Clarivate PLC
CLVT4.290USD
+0.059+1.42%
Cierre 06/16, 16:00（ET）Cotizaciones retrasadas 15 min
2.93BCap. mercado
PérdidaP/E TTM
Más Datos de Clarivate PLC Compañía
Clarivate Plc is a global provider of transformative intelligence. The Company offers enriched data, insights and analytics, workflow solutions and expert services in the areas of Academia & Government (A&G), Intellectual Property (IP) and Life Sciences & Healthcare (LS&H). Within the A&G segment, the Company provides research and analytics, content aggregation, and workflow software solutions. Within the IP segment, the Company provides IP Maintenance, IP Intelligence, and IP Management solutions. Within the LS&H segment, the Company provides research and development, regulatory and safety, and commercialization solutions. It is also a provider of cloud-based solutions that enable life sciences clients to automate regulatory reporting and compliance management. It is also engaged in providing comprehensive and integrated solutions to support patent preparation, filing and prosecution, offering patent practitioners with automation and artificial intelligence (AI)-enabled solutions.
Información de la empresa
Símbolo de cotizaciónCLVT
Nombre de la empresaClarivate PLC
Fecha de salida a bolsaOct 29, 2018
Fundada en2019
Director ejecutivoMr. Matitiahu Shem (Matti) Tov
Número de empleados12000
Tipo de seguridadOrdinary Share
Fin del año fiscalOct 29
Dirección70 St. Mary Axe
CiudadLONDON
Bolsa de valoresNYSE Consolidated
PaísUnited Kingdom
Código postalEC3A 8BE
Teléfono442074334000
Sitio Webhttps://clarivate.com/
Símbolo de cotizaciónCLVT
Fecha de salida a bolsaOct 29, 2018
Fundada en2019
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Bar Veinstein
Mr. Bar Veinstein
President - Academia and Government
President - Academia and Government
729.15K
+150.40%
Mr. Jonathan Mark Collins
Mr. Jonathan Mark Collins
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
488.98K
+10.04%
Mr. Henry Levy
Mr. Henry Levy
President - Life Sciences and Health care
President - Life Sciences and Health care
411.80K
-8.81%
Dr. Saurabh Saha, M.D., Ph.D.
Dr. Saurabh Saha, M.D., Ph.D.
Independent Director
Independent Director
116.52K
+42.06%
Dr. Wendell E. Pritchett
Dr. Wendell E. Pritchett
Independent Director
Independent Director
101.81K
+41.73%
Ms. Valeria Alberola
Ms. Valeria Alberola
Independent Director
Independent Director
91.16K
+57.91%
Mr. Jane Okun Bomba, CPA
Mr. Jane Okun Bomba, CPA
Independent Director
Independent Director
--
--
Ms. Suzanne Heywood
Ms. Suzanne Heywood
Independent Director
Independent Director
--
--
Mr. Usama N. Cortas
Mr. Usama N. Cortas
Independent Director
Independent Director
--
--
Mr. Mark Donohue
Mr. Mark Donohue
Vice President - Investor Relations
Vice President - Investor Relations
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Bar Veinstein
Mr. Bar Veinstein
President - Academia and Government
President - Academia and Government
729.15K
+150.40%
Mr. Jonathan Mark Collins
Mr. Jonathan Mark Collins
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
488.98K
+10.04%
Mr. Henry Levy
Mr. Henry Levy
President - Life Sciences and Health care
President - Life Sciences and Health care
411.80K
-8.81%
Dr. Saurabh Saha, M.D., Ph.D.
Dr. Saurabh Saha, M.D., Ph.D.
Independent Director
Independent Director
116.52K
+42.06%
Dr. Wendell E. Pritchett
Dr. Wendell E. Pritchett
Independent Director
Independent Director
101.81K
+41.73%
Ms. Valeria Alberola
Ms. Valeria Alberola
Independent Director
Independent Director
91.16K
+57.91%
Desglose de ingresos
Divisa: USDActualizado: dom., 6 de abr
Divisa: USDActualizado: dom., 6 de abr
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Por negocioUSD
Nombre
Ganancia
Proporción
Subscription revenues
1.63B
63.63%
Transactional revenues
500.10M
19.56%
Re-occurring revenues
429.80M
16.81%
Por regiónUSD
Nombre
Ganancia
Proporción
Americas
1.38B
54.03%
Europe/ Middle East /Africa
667.80M
26.12%
Asia Pacific
507.50M
19.85%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Subscription revenues
1.63B
63.63%
Transactional revenues
500.10M
19.56%
Re-occurring revenues
429.80M
16.81%
Estadísticas de accionistas
Actualizado: sáb., 17 de may
Actualizado: sáb., 17 de may
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Leonard Green & Partners, L.P.
17.08%
Clarkston Capital Partners, LLC
10.91%
Giovanni Agnelli B V
9.85%
Impactive Capital LP
6.30%
Onex Corporation
6.14%
Other
49.72%
Accionistas
Accionistas
Proporción
Leonard Green & Partners, L.P.
17.08%
Clarkston Capital Partners, LLC
10.91%
Giovanni Agnelli B V
9.85%
Impactive Capital LP
6.30%
Onex Corporation
6.14%
Other
49.72%
Tipos de accionistas
Accionistas
Proporción
Private Equity
30.46%
Investment Advisor
28.17%
Investment Advisor/Hedge Fund
15.54%
Hedge Fund
14.68%
Holding Company
9.85%
Corporation
5.58%
Pension Fund
1.73%
Individual Investor
1.04%
Sovereign Wealth Fund
0.85%
Participación institucional
Actualizado: sáb., 22 de feb
Actualizado: sáb., 22 de feb
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q1
677
774.53M
113.38%
-133.10M
2024Q4
712
766.77M
110.84%
-166.20M
2024Q3
726
765.53M
108.25%
-158.23M
2024Q2
741
760.08M
105.78%
-120.39M
2024Q1
752
730.14M
108.67%
-137.39M
2023Q4
783
725.50M
108.90%
-179.38M
2023Q3
791
741.16M
111.25%
-79.71M
2023Q2
796
712.25M
105.35%
-100.17M
2023Q1
777
702.68M
104.01%
-43.46M
2022Q4
788
663.31M
98.18%
-69.01M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Leonard Green & Partners, L.P.
116.67M
16.93%
--
--
Dec 31, 2024
Clarkston Capital Partners, LLC
70.73M
10.27%
-1.48M
-2.04%
Dec 31, 2024
Giovanni Agnelli B V
67.29M
9.77%
--
--
Dec 31, 2024
Impactive Capital LP
43.03M
6.25%
+3.40M
+8.58%
Dec 31, 2024
Onex Corporation
42.86M
6.22%
--
--
Mar 15, 2024
Selige Co-Investor Pooling SCSp
38.09M
5.53%
--
--
Mar 15, 2024
Partners Group AG
25.58M
3.71%
--
--
Dec 31, 2024
Cambridge Information Group, Inc.
23.61M
3.43%
--
--
Mar 15, 2024
Dimensional Fund Advisors, L.P.
14.46M
2.1%
-38.61K
-0.27%
Dec 31, 2024
Fidelity Investments Canada ULC
15.29M
2.22%
-1.75M
-10.27%
Dec 31, 2024
Ver más
ETFs relacionados
Actualizado: vie., 6 de jun
Actualizado: vie., 6 de jun
Nombre
Proporción
AGF US Market Neutral Anti-Beta Fund
0.52%
First Trust Technology Alphadex
0.35%
WisdomTree US MidCap Fund
0.2%
JPMorgan US Value Factor ETF
0.19%
Avantis US Small Cap Value ETF
0.16%
John Hancock Multifactor Small Cap ETF
0.15%
Nuveen ESG Small-Cap ETF
0.15%
DFA Dimensional US Small Cap Value ETF
0.13%
T Rowe Price Small-Mid Cap ETF
0.12%
BNY Mellon US Small Cap Core Equity ETF
0.1%
Ver más
AGF US Market Neutral Anti-Beta Fund
Proporción0.52%
First Trust Technology Alphadex
Proporción0.35%
WisdomTree US MidCap Fund
Proporción0.2%
JPMorgan US Value Factor ETF
Proporción0.19%
Avantis US Small Cap Value ETF
Proporción0.16%
John Hancock Multifactor Small Cap ETF
Proporción0.15%
Nuveen ESG Small-Cap ETF
Proporción0.15%
DFA Dimensional US Small Cap Value ETF
Proporción0.13%
T Rowe Price Small-Mid Cap ETF
Proporción0.12%
BNY Mellon US Small Cap Core Equity ETF
Proporción0.1%
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
